Monocytes and macrophages make up part of the innate immune system and provide one of the first defenses against variety of treats. Macrophages can also modulate the adaptive immune system. Efficient sensing and response to tissue environmental cues highlights the complexity and dynamic nature of macrophages and their plasticity. Macrophages may have divergent roles depending on their polarity and stimulus received. Accumulating evidence demonstrates the critical role played by macrophages in tumor initiation, development, and progression. In this review, we discuss the characteristics of tumor-associated macrophages (TAMs) and their role in pancreatic adenocarcinoma. In addition, we give an overview on recent advances related to the therap...
Macrophages are crucial drivers of tumour-promoting inflammation. Tumour-associated macrophages (TAM...
Tumor-associated macrophages (TAMs) are key components of the tumor macroenvironment. Cancer- and ho...
At the time of diagnosis, almost 80% of pancreatic cancer patients present with new-onset type 2 dia...
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignant disease with a 5-year survival ra...
Despite modest improvements in survival in recent years, pancreatic adenocarcinoma remains a deadly ...
Abstract Pancreatic ductal adenocarcinoma (PDA) is a lethal disease that is usually diagnosed at lat...
Pancreatic cancer is considered as one of the most lethal types of cancer due to its poor prognosis ...
Abstract The fact that various immune cells, including macrophages, can be found in tumor tissues ha...
Despite modest improvements in survival in recent years, pancreatic adenocarcinoma remains a deadly ...
Abstract The fact that various immune cells, including macrophages, can be found in tumor tissues ha...
OBJECTIVE: Tumour-associated macrophages (TAMs) play key roles in tumour progression. Recent eviden...
During tumor progression, circulating monocytes and macrophages are actively recruited into tumors w...
Macrophages are one of the most important cells of the innate immune system and are known for their ...
Obesity is a known risk factor for the development of pancreatic cancer, one of the deadliest types ...
Macrophages abound in the tumor microenvironment of pancreatic cancer and other solid malignancies. ...
Macrophages are crucial drivers of tumour-promoting inflammation. Tumour-associated macrophages (TAM...
Tumor-associated macrophages (TAMs) are key components of the tumor macroenvironment. Cancer- and ho...
At the time of diagnosis, almost 80% of pancreatic cancer patients present with new-onset type 2 dia...
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignant disease with a 5-year survival ra...
Despite modest improvements in survival in recent years, pancreatic adenocarcinoma remains a deadly ...
Abstract Pancreatic ductal adenocarcinoma (PDA) is a lethal disease that is usually diagnosed at lat...
Pancreatic cancer is considered as one of the most lethal types of cancer due to its poor prognosis ...
Abstract The fact that various immune cells, including macrophages, can be found in tumor tissues ha...
Despite modest improvements in survival in recent years, pancreatic adenocarcinoma remains a deadly ...
Abstract The fact that various immune cells, including macrophages, can be found in tumor tissues ha...
OBJECTIVE: Tumour-associated macrophages (TAMs) play key roles in tumour progression. Recent eviden...
During tumor progression, circulating monocytes and macrophages are actively recruited into tumors w...
Macrophages are one of the most important cells of the innate immune system and are known for their ...
Obesity is a known risk factor for the development of pancreatic cancer, one of the deadliest types ...
Macrophages abound in the tumor microenvironment of pancreatic cancer and other solid malignancies. ...
Macrophages are crucial drivers of tumour-promoting inflammation. Tumour-associated macrophages (TAM...
Tumor-associated macrophages (TAMs) are key components of the tumor macroenvironment. Cancer- and ho...
At the time of diagnosis, almost 80% of pancreatic cancer patients present with new-onset type 2 dia...